Cargando…

Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer

Y‐box binding protein‐1 (YBX1), a multifunctional oncoprotein containing an evolutionarily conserved cold shock domain, dysregulates a wide range of genes involved in cell proliferation and survival, drug resistance, and chromatin destabilization by cancer. Expression of a multidrug resistance‐assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuwano, Michihiko, Shibata, Tomohiro, Watari, Kosuke, Ono, Mayumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500994/ https://www.ncbi.nlm.nih.gov/pubmed/30903644 http://dx.doi.org/10.1111/cas.14006

Ejemplares similares

Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer
por: Shibata, Tomohiro, et al.
Publicado: (2018)

Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma
por: Watari, Kosuke, et al.
Publicado: (2016)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice
por: Watari, Kosuke, et al.
Publicado: (2016)

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells
por: Watari, Kosuke, et al.
Publicado: (2020)

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
por: Azuma, Koichi, et al.
Publicado: (2014)

Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
por: Watari, Kosuke, et al.
Publicado: (2014)

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes
por: Murakami, Yuichi, et al.
Publicado: (2019)

N-myc Downstream Regulated Gene 1 (NDRG1) Promotes Metastasis of Human Scirrhous Gastric Cancer Cells through Epithelial Mesenchymal Transition
por: Ureshino, Hiroki, et al.
Publicado: (2012)

The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutated EGFR gene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cells
por: Murakami, Yuichi, et al.
Publicado: (2017)

Heparin‐binding Epidermal Growth Factor‐like Growth Factor: p91 Activation, Induction of Plasminogen Activator/Plasminogen Activator Inhibitor, and Tubular Morphogenesis in Human Microvascular Endothelial Cells
por: Ushiro, Shin, et al.
Publicado: (1996)

Co‐expression of Thymidine Phosphorylase and Heme Oxygenase‐1 in Macrophages in Human Malignant Vertical Growth Melanomas
por: Torisu‐Itakura, Hitoe, et al.
Publicado: (2000)

Chemical Composition of the Essential Oil of Mastic Gum and their Antibacterial Activity Against Drug-Resistant Helicobacter pylori
por: Miyamoto, Tomofumi, et al.
Publicado: (2014)

Altered Expression of Epidermal Growth Factor Receptor Gene in a Classical Multidrug‐resistant Variant of a Human Cancer Cell Line, KB
por: Takano, Hiroshi, et al.
Publicado: (1989)

Overexpression of Multidrug Resistance Protein Gene in Human Cancer Cell Lines Selected for Drug Resistance to Epipodophyllotoxins
por: Koike, Koji, et al.
Publicado: (1996)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets
por: Sadaf, et al.
Publicado: (2023)

Cooperative Roles of Hepatocyte Growth Factor and Plasminogen Activator in Tubular Morphogenesis by Human Microvascular Endothelial Cells
por: Morimoto, Akio, et al.
Publicado: (1994)

Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8
por: Wakabayashi, Yukihiro, et al.
Publicado: (1995)

LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer
por: Li, Shanshan, et al.
Publicado: (2022)

Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human Glioma
por: Haga, Sei, et al.
Publicado: (2001)

Biomodulation by Hyperthermia of Topoisomerase II‐Targeting Drugs in Human Colorectal Cancer Cells
por: Hirohashi, Yoshimi, et al.
Publicado: (1995)

Potentiation of Some Anticancer Agents by Dipyridamole against Drug‐sensitive and Drug‐resistant Cancer Cell Lines
por: Asoh, Kuni‐ichi, et al.
Publicado: (1989)

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma
por: D’Costa, Ninadh M., et al.
Publicado: (2020)

Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target
por: Maurya, Pramod Kumar, et al.
Publicado: (2017)

X-box binding protein 1: A new metabolic mediator and drug target of metformin?
por: Lou, Kai, et al.
Publicado: (2022)

Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
por: Fujiwara-Okada, Y, et al.
Publicado: (2013)

Carboxyl‐terminal Heparin‐binding Fragments of Platelet Factor 4 Retain the Blocking Effect on the Receptor Binding of Basic Fibroblast Growth Factor
por: Sato, Yasufumi, et al.
Publicado: (1993)

All‐trans‐retinoic Acid‐dependent Inhibition of E‐Cadherin‐based Cell Adhesion with Concomitant Dephosphorylation of β‐Catenin in Metastatic Human Renal Carcinoma Cells
por: Ryuto, Masahiro, et al.
Publicado: (1997)

MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma
por: Bell, Jessica L., et al.
Publicado: (2020)

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
por: Ndieyira, Joseph W., et al.
Publicado: (2013)

WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target
por: Zhang, Zhiwei, et al.
Publicado: (2023)

Zinc finger E-box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Liao, Li-Zhu, et al.
Publicado: (2020)

Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Oncogenic AKTivation of translation as a therapeutic target
por: Hsieh, A C, et al.
Publicado: (2011)

Oncogenes in immune cells as potential therapeutic targets
por: Zakiryanova, Gulnur K, et al.
Publicado: (2018)

Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control
por: Mordovkina, Daria, et al.
Publicado: (2020)

Integrin β8 facilitates tumor growth and drug resistance through a Y‐box binding protein 1‐dependent signaling pathway in bladder cancer
por: Liu, Shimin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4due684egc3m32cjih1rs1u9hm